SCHEMBL19903617

SCHEMBL19903617

Cc1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cc(C#N)cc(-n3c4ccccc4c4cc(-c5ccc(C)cc5)ccc43)c2-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.38
RXRA P19793 1/20 0.37
RXRG P48443 1/20 0.37
TACR1 P25103 5/20 0.36
PDE9A O76083 2/20 0.35
PDE1C Q14123 2/20 0.35
KIF11 P52732 2/20 0.35
PTPN5 P54829 2/20 0.33
ICMT O60725 2/20 0.33
PTGER4 P35408 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20617171 0.98 RXRA (0.39) ARRXRARXRGTACR1PDE9A
SCHEMBL19912488 0.96 AR (0.36) ARRXRARXRGTACR1PDE9A
SCHEMBL19917932 0.95 AR (0.41) ARRXRARXRGTACR1KIF11
SCHEMBL19917947 0.94 RXRA (0.36) ARRXRARXRGTACR1PDE9A
SCHEMBL19917945 0.94 AR (0.38) ARRXRARXRGTACR1PDE9A
SCHEMBL19903668 0.94 RXRA (0.41) RXRARXRGTACR1KIF11PTPN5
SCHEMBL19917974 0.94 KIF11 (0.42) RXRARXRGTACR1KIF11PTPN5
SCHEMBL19903528 0.94 RXRA (0.40) RXRARXRGTACR1KIF11PTPN5
SCHEMBL19917966 0.93 AR (0.41) ARRXRARXRGTACR1KIF11
SCHEMBL19912476 0.93 RXRA (0.38) ARRXRARXRGTACR1PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 AR 4190/4885RXRA 3779/4885RXRG 3669/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 AR 4212/4885RXRA 3635/4885RXRG 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.